Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Phenomenex
Phenomenex
Activities:
Manufacturing
Research & Development
Analysis
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Analysis
Phenomenex opens new gas chromatography research and manufacturing facility
The 15,000sqft facility is located in Sacramento, CA and supports twice the production capacity
Analysis
Polar, mixed-mode selectivities added to Luna HPLC/UHPLC column line
This mixed-mode selectivity is a tool for separation of compound mixtures that have varying functional groups, such as peptides, pesticides or metabolite profiles
Manufacturing
Phenomenex expands into Spain with purchase of Micron Analitica
Will enable the US company to tailor its products for the Spanish market
Ingredients
Free chiral screening service for drugs
Phenomenex has introduced a chiral screening service for customers in pharmaceutical r&d
Subscribe now